Podcasts

RNA Exon Editing with Ascidian Therapeutics' Drs. Robert Bell and Michael Ehlers

Listen to the latest Molecular Therapy Podcast! - January 07, 2025

This conversation explores Dr. Bell's recent MTNA publication "RNA Exon Editing: Splicing the Way to Treat Human Diseases."

Follow the ASGCT Podcast Network wherever you listen to podcasts!

     

Join Dr. Paloma Giangrande, Editor-in-Chief of Molecular Therapy Nucleic Acids, as she discusses RNA exon editing with Ascidian Therapeutics' leadership: CSO Dr. Robert Bell and CEO Dr. Michael Ehlers. Their conversation explores Dr. Bell's recent MTNA publication "RNA Exon Editing: Splicing the Way to Treat Human Diseases."

Last Call: Submit your abstracts for ASGCT's 2025 Annual Meeting in New Orleans by January 31st, 11:59 PM ET. Present at cell and gene therapy's premier event and get published in Molecular Therapy. Details at annualmeeting.asgct.org/abstracts.

In This Episode

Paloma Giangrande, PhD
Editor-in-Chief, Molecular Therapy Nucleic Acids and Chief Technology Officer at Eleven Therapeutics

Robert Bell, PhD
Chief Scientific Officer at Ascidian Therapeutics

Michael Ehlers, MD, PhD
President and Chief Executive Officer at Ascidian Therapeutics

'Electric Dreams' by Scott Buckley - released under CC-BY 4.0.
www.scottbuckley.com.au

Related Articles

Annual Meeting 2025

A Vaccine for Cocaine Addiction with Dr. Stephen Kaminsky

Listen + subscribe - July 22, 2025
Podcasts

25 Years of Molecular Therapy with Drs. Beverly Davidson and Jeff Chamberlain

Listen + subscribe to the ASGCT Podcast Network - July 16, 2025
Annual Meeting 2025

Developing Therapeutic Platforms with Dr. P.J. Brooks

Listen + subscribe to the ASGCT Podcast Network - July 09, 2025
Podcasts

The Ups and Downs of Conducting Groundbreaking Research with Dr. Kiran Musunuru

Listen + subscribe to the ASGCT Podcast Network! - June 16, 2025